University of Maryland School of Medicine
Assistant Professor With the Center For Vaccine Development and Global Health
University of Maryland School of Medicine Oct 2017 - Feb 2019
Research Associate With the Center For Vaccine Development and Global Health
University of Maryland School of Medicine Sep 2016 - Sep 2017
Postdoctoral Fellow With the Center For Vaccine Development and Global Health
Yale School of Public Health Jan 2015 - Jul 2016
Postdoctoral Associate at the Center For Infectious Disease Modeling and Analysis
University of Maryland School of Medicine Jul 2007 - Jul 2008
Research Assistant
Education:
Yale University 2008 - 2014
Doctorates, Doctor of Philosophy, Epidemiology, Public Health
University of Notre Dame 2002 - 2006
Bachelors, Bachelor of Science
Villa Maria Academy 1998 - 2002
Skills:
Pcr Molecular Biology Data Analysis Laboratory Infectious Diseases Western Blotting Science Cell Culture Genetics Gel Electrophoresis Elisa Microscopy Statistics Public Health Computational Biology Biostatistics Epidemiology Mathematical Modeling Cell Biology Lifesciences R Qpcr In Vitro Scientific Writing Immunofluorescence Immunology Experimental Design Life Sciences
The virus trajectory in the United States has often, but not always, followed the pattern in Europe, said Dr. Meagan Fitzpatrick, an infectious disease transmission modeler at the University of Maryland School of Medicine. What any given state or region will experience depends on how many people cu
Date: Mar 24, 2022
Category: More news
Source: Google
Two charts show the extraordinary success of Covid-19 vaccines
were estimated to have prevented 1.1 million hospitalizations and halted 14 million infections, showing that more than 338 million doses had a powerful effect. It was larger than we wouldve expected, said coauthor Meagan Fitzpatrick, an infectious disease modeler at the University of Maryland.
Date: Jan 27, 2022
Category: More news
Source: Google
Detroit expands COVID-19 vaccine eligibility again, doesn't plan to offer single-shot version
Dr. Meagan Fitzpatrick, an assistant professor at the University of Maryland School of Medicine who is studying infectious disease control strategies, said the main advantage of the Johnson & Johnson vaccine is the stability it offers. Unlike the Moderna and Pfizer vaccines, it doesnt need to b
Date: Mar 02, 2021
Category: More news
Source: Google
When will the Covid-19 pandemic end? Vaccine roll-out is still murky.
That would give us potentially some information for what future years will look like, said Meagan Fitzpatrick, an assistant professor at the center for vaccine development and global health at the University of Maryland School of Medicine. You will definitely get some signal, but you dont know r
Date: Dec 28, 2020
Category: More news
Source: Google
A Covid-19 vaccine may not be enough to end the pandemic
Without a vaccine, its not as though we can do nothing, said Meagan Fitzpatrick, an assistant professor at the center for vaccine development and global health at the University of Maryland School of Medicine. With or without a vaccine, what we really need to be doing in the short term is contac